#451: A new biomarker for depression?

This week, James is joined by Ben Finlay, Partner at Stratt and Advisor to Ranvier.ai, to dig into why mental health is still diagnosed by questionnaire - and what a taste test, a blood biomarker and a continuum view of neurological wellness could change. Ben shares the science behind Ranvier's objective mood measurement, the journey from early intervention in depression through to staving off Alzheimer's and Parkinson's, and a candid look at where pharma, policy and AI are heading next.Connect with Ben: https://www.linkedin.com/in/benfinlay/Learn more: https://www.ranvier.ai/Apply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦: www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comThis podcast was brought to you by SomX.